focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,092.00
Bid: 12,090.00
Ask: 12,094.00
Change: -80.00 (-0.66%)
Spread: 4.00 (0.033%)
Open: 12,180.00
High: 12,188.00
Low: 12,084.00
Prev. Close: 12,172.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London stocks lag as miners slip; AstraZeneca weighs

Mon, 19th Jun 2023 17:09

AstraZeneca down on report of China business spin off plan

*

Inflation data, BoE rate decision due this week

*

Fashion retailer Next up on guidance raise

*

FTSE 100 down 0.7%, FTSE 250 off 0.9%

June 19 (Reuters) - The UK's resources-heavy benchmark index slipped on Monday, dragged by mining stocks which tracked metal prices lower, while shares of pharmaceutical major AstraZeneca slipped on a report of the drugmaker's plans to spin off its China business.

The FTSE 100 slipped 0.7% as miners of both industrial metals and precious metals slipped 1.8% and 1.7%, respectively.

A firmer dollar weighed on copper and gold prices, while a lack of detail on economic stimulus in top consumer China further dented sentiment.

A Reuters survey showed that China is widely expected to cut key lending benchmarks on Tuesday as authorities seek to shore up a slowing economic recovery.

AstraZeneca fell 1.2%, dragging the healthcare sector down 1.1% on the report saying the company plans to spin off its China business and is considering a separate unit listing in Hong Kong.

The FTSE 250 mid-cap index also fell, by 0.9%.

Investor focus will remain on domestic inflation data due Wednesday to assess the state of economy, leading up to the Bank of England's decision on monetary policy on Thursday, with traders almost fully pricing in another 25-basis-point hike.

"For the BoE, the May inflation print will do little to shift the Monetary Policy Committee's thinking around a June rate hike as we believe a quarter-point hike is very likely a done deal," said Sanjay Raja, chief UK economist at Deutsche Bank Research.

"At most, an upside surprise could trigger more hawkish forward guidance, with the MPC potentially doubling down on its efforts to tackle excess inflation," Raja said.

British two-year government bond yields rose to 5% for the first time since July 2008.

Bucking the trend, Next advanced 4.7% after the fashion retailer raised its sales and profit guidance for the year.

The broader retailers index rose 0.9%.

Meanwhile, a survey showed a decline in asking prices for British homes in June for the first time in six years, indicating an earlier-than-usual summer slowdown amid mortgage market turmoil.

The UK's homebuilding sector dropped 1.1%.

Trading was thin as U.S. markets were closed for the Juneteenth holiday on Monday. (Reporting by Ankika Biswas and Shashwat Chauhan in Bengaluru; Editing by Nivedita Bhattacharjee, Sonia Cheema and Jonathan Oatis)

More News
13 Feb 2024 09:32

LONDON BROKER RATINGS: Citi lifts GSK; Shore likes XPS Pensions

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
12 Feb 2024 12:04

LONDON MARKET MIDDAY: FTSE 100 underperforms as European peers rise

(Alliance News) - London's FTSE 100 underwhelmed on Monday, with some of its largest constituents pulling it lower, while indices in Europe were on the up on favourable comments on interest rate cuts by a European Central Bank official.

Read more
12 Feb 2024 09:41

LONDON BROKER RATINGS: Deutsche Bank starts Deliveroo at 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
12 Feb 2024 09:12

Barclays sees "compelling" entry point at AstraZeneca after recent falls

(Sharecast News) - Barclays has kept an 'overweight' position on AstraZeneca despite the biopharma group's disappointing annual results last week, saying that the stock's recent underperformance provides an attractive entry point for investors.

Read more
9 Feb 2024 09:15

LONDON BROKER RATINGS: Deutsche Bank cuts AstraZeneca to 'sell'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
9 Feb 2024 07:51

LONDON BRIEFING: Barclays buys Tesco's retail banking business

(Alliance News) - Stocks in London are called to open higher on Friday, closing off a busy corporate week.

Read more
8 Feb 2024 17:00

LONDON MARKET CLOSE: Softer earnings weigh on underperforming FTSE 100

(Alliance News) - London's FTSE 100 ended lower on Thursday, with mixed corporate updates keeping a lid on enthusiasm, while in New York the S&P 500 has the 5,000 point mark in touching distance.

Read more
8 Feb 2024 14:42

London close: Stocks slip as US jobless claims fall

(Sharecast News) - London markets experienced a downturn in trading on Thursday, with stocks relinquishing earlier gains as investors processed a decrease in jobless claims in the United States.

Read more
8 Feb 2024 12:08

LONDON MARKET MIDDAY: DS Smith surges on takeover approach from Mondi

(Alliance News) - Stock prices in London were mixed at midday Thursday, as markets struggled to find direction amid a mixed wave of corporate updates and earnings.

Read more
8 Feb 2024 08:59

LONDON MARKET OPEN: Unilever up on buyback; BAT ups dividend

(Alliance News) - THE FTSE 100 in London opened slightly higher on Thursday, with earnings from British American Tobacco and Unilever boosting the index.

Read more
8 Feb 2024 08:44

TOP NEWS: AstraZeneca confident after 2023 profit more than doubles

(Alliance News) - AstraZeneca PLC on Thursday said it expects another year of strong growth after reporting pretax profit in 2023 more than doubled.

Read more
8 Feb 2024 07:58

AstraZeneca shares slip as Q4 profits miss forecasts

(Sharecast News) - Biopharma titan AstraZeneca delivered a 6% increase in sales in 2023 despite a $3.7bn decline in Covid-19 medicines revenues, as it guided to a strong pick-up in growth this year - though profits came in slightly under analysts' forecasts.

Read more
8 Feb 2024 07:50

LONDON BRIEFING: Unilever sets new buyback; Astra profit surges

(Alliance News) - Stocks in London are called to open slightly higher on Thursday, as investors eye a busy day of earnings.

Read more
2 Feb 2024 08:38

AstraZeneca celebrates latest successful trial of acoramidis in Japan

(Alliance News) - AstraZeneca PLC on Friday said positive results from a Phase 3 trial of acoramidis are consistent with global findings, bring the drug closer to regulatory submission in Japan.

Read more
2 Feb 2024 06:22

TOP NEWS: US sends drugmakers initial offers in Medicare price talks

(Alliance News) - The US government said it was making initial offers to drugmakers Thursday as part of Medicare negotiations meant to lower the prices many older Americans would pay for 10 medicines.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.